SCHEDULE 13G Filed 2026-10-05 Event — SEC 0001104659-26-113805 →

INTEGRATED CORE STRATEGIES (US) LLC → First Horizon Corporation FHN-PF

Stake: — Shares: — Class: Common Capital Stock, par value $0.625 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

2 holders · $88.45M

Greenlight CapitalPoint72 Asset Mgmt

Other 13D/G Filings on First Horizon Corporation

Filed	Form	Filer	Stake	Shares
2026-09-09	SCHEDULE 13G	MILLENNIUM MANAGEMENT LLC	—	—	view →

Other Filings by INTEGRATED CORE STRATEGIES (US) LLC

Filed	Form	Issuer	Stake	Shares
2026-09-22	SCHEDULE 13G	Better Home & Finance Holding Company	—	—	view →
2026-09-04	SCHEDULE 13G	Karyopharm Therapeutics Inc.	—	—	view →
2026-09-01	SCHEDULE 13G	Fortress Biotech, Inc.	—	—	view →
2026-08-24	SCHEDULE 13G	Collegium Pharmaceutical, Inc.	—	—	view →
2026-08-24	SCHEDULE 13G	Tenaya Therapeutics, Inc.	—	—	view →
2026-06-18	SCHEDULE 13G	Edesa Biotech, Inc. EDSA	—	—	view →
2026-06-17	SCHEDULE 13G	TPG Inc. TPGXL	—	—	view →
2026-06-11	SCHEDULE 13G	Once Upon a Farm, PBC OFRM	—	—	view →
2026-06-10	SCHEDULE 13G	Quince Therapeutics, Inc. QNCX	—	—	view →
2026-05-26	SCHEDULE 13G	Amanat Acquisition Corp AMAN	—	—	view →
2018-01-08	SC	TETRAPHASE PHARMACEUTICALS INC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →